Top section
Top section
I thought the grass would be greener in fintech land, but it’s patchy and dreary
Hybrid capital is open to the big US tech companies. But who needs an umbrella when the sun is shining?
Years of underperformance are behind it and the bank has launched a new growth plan
More articles
More articles
More articles
-
Sir Ronald Cohen, one of the UK’s foremost private equity entrepreneurs, believes the Covid-19 crisis is an opportunity to transform western capitalism into a socially responsible enterprise that values a company’s impact on society as much as its profits. Cohen talks to GlobalCapital about the tremendous challenges facing the global economy, and how it can be transformed for the better. -
BP’s announcement that it was selling $5bn of assets to Ineos — a sale the already leveraged group will fund largely through new debt — put selling pressure on existing Ineos debt on Monday; particularly that issued by its Styrolution unit, which will be the acquirer in the BP deal.
-
Equity issuance has surged during the Covid-19 pandemic in both Europe and the US, and one of the sectors that has printed the most stock in the first half of the year is the biopharmaceuticals industry. In the rush for healthcare innovation, banks say they are busy lining up more deals for the second half.
-
Redefine Properties, the South African real estate company focused on commercial properties, has completed a buy-back of its outstanding €117.2m 1.5% exchangeable bonds due 2021, as part of a wider restructuring of the firm.
-
UBS has created a new corporate finance group within the Greater China team that will mainly focus on the execution of IPOs, according to an internal memo seen by GlobalCapital Asia.
-
WuXi Biologics (Cayman) bagged HK$6.17bn ($795m) on Monday after boosting the size of a new equity issuance.
Sub-sections
shared comment list
